OrthO-rheumatO | VOL 11 | Nr 2 | 2013
9
referenties
1. dougados m, landewe r. spondyloarthritis: pathogenesis, clinical aspects and diagnosis.
in: Bijlsma j, ed. eular compendium on rheumatic diseases. Bmj Publishing group
2009:92115.
2. moll jmh, haslock i, macrae if, et al. associations between ankylosing-spondylitis,
psoriatic arthritis, reiters disease, intestinal arthropathies and Behcets syndrome.
medicine 1974;53:343-64.
3. rudwaleit m, van der heijde d, landewe r, et al. The development of assessment of
spondyloarthritis international society classification criteria for axial spondyloarthritis
(part ii): validation and final selection. ann rheum dis 2009;68:777-83.
4. rudwaleit m, van der heijde d, landewe r, et al. The assessment of spondyloarthritis
international society classification criteria for peripheral spondyloarthritis and for
spondyloarthritis in general. ann rheum dis 2011;70:25-31.
5. elewaut d, matucci-Cerinic m. Treatment of ankylosing spondylitis and extra-articular
manifestations in everyday rheumatology practice. rheumatology 2009;48:1029-35.
6. Carron P, Van Praet l, jacques P, et al. Therapy for spondyloarthritis: The role of extra-
articular manifestations (eye, skin). rheum dis Clin north am 2012;38:583-600.
7. de keyser f, elewaut d, de Vos m, et al. Bowel inflammation and the
spondyloarthropathies. rheum dis Clin north am 1998;24:785-813.
8. de Vlam k, mielants h, Cuvelier C, et al. spondyloarthropathy is underestimated
in inflammatory bowel disease: Prevalence and hla association. j rheumatol
2000;27:2860-5.
9. leirisalo-repo m. Prognosis, course of disease, and treatment of the
spondyloarthropathies. rheum dis Clin n am 1998;24:737-51.
10. de Vos m, Cuvelier C, mielants h, et al. ileocolonoscopy in seronegative
spondylarthropathy. gastroenterology 1989;96:339-44.
11. mielants h, Veys em, Cuvelier C, et al. hla-B27 related arthritis and bowel inflammation.
Part 2. ileocolonoscopy and bowel histology in patients with hla-B27 related arthritis. j
rheumatol 1985;12:294-8.
12. de Vos m, mielants h, Cuvelier C, et al. long-term evolution of gut inflammation in
patients with spondyloarthropathy. gastroenterology 1996;1696-703.
13. duerr rh, Taylor kd, Brant sr, et al. a genome-wide association study identifies il23r as
an inflammatory bowel disease gene. science 2006;314:1461-3.
14. rahman P, inman rd, gladman dd, et al. association of interleukin-23 receptor variants
with ankylosing spondylitis. arthritis rheum 2008;58:1020-5.
15. laukens d, Peeters h, marichal d, et al. Card15 gene polymorphisms in patients with
spondyloarthropathies identify a specific phenotype previously related to Crohn's
disease. ann rheum dis 2005;64:930-5.
16. sartor rB. mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis.
nat Clin Pract gastroenterol hepatol 2006;3:390-407.
17. frank dn, st amand al, feldman ra, et al. molecular-phylogenetic characterization of
microbial community imbalances in human inflammatory bowel diseases. Proc natl acad
sci u s a 2007;104:13780-5.
18. Taurog jd, richardson ja, Croft jT, et al. The germfree state prevents development of gut
and joint inflammatory disease in hla-B27 transgenic rats. j exp med 1994;180:2359-64.
19. mundwiler ml, mei l, landers Cj, et al. inflammatory bowel disease serologies in
ankylosing spondylitis patients: a pilot study. arthritis res Ther 2009;11:r177.
20. de Vries m, van der horst-Bruinsma i, van hoogstraten i, et al. panCa, asCa, and ompC
antibodies in patients with ankylosing spondylitis without inflammatory bowel disease.
j rheumatol 2010;37:2340-4.
21. jacques P, elewaut d. joint expedition: linking gut inflammation to arthritis. mucosal
immunol 2008;1:364-71.
22. Baeten d, demetter P, Cuvelier Ca, et al. macrophages expressing the scavenger receptor
Cd163: a link between immune alterations of the gut and synovial inflammation in
spondyloarthropathy. j Pathol 2002;196:343-50.
23. Van Praet l, Van den Bosch fe, jacques P, et al. microscopic gut inflammation in axial
spondyloarthritis: a multiparametric predictive model. ann rheum dis 2012 nov 8.
[epub ahead of print]
TRB CHEMEDICA AG · Postbus 1129 · 85529 Haar/München, Duitsland · info@trbchemedica.be · www.trbchemedica.be
Voor de behandeling van pijn
en beperkte bewegingsvrijheid
bij peesaandoeningen.
00513_Anz_OstenilTendon_210x148,5+5_NL-FR.indd 1
25.02.13 18:23